CLINICAL_TRIALS
trial_result
· 2019-04-03
Clinical Trial Update: Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome [Phase 2]
Summary
Phase 2 clinical trial evaluating brain imaging with nuclear technology in individuals with Parkinson's disease and Parkinsonian syndrome completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Institute for Neurodegenerative Disorders | Conditions: Parkinson's Disease, Parkinsonian Syndrome | Phase 2 | Status: COMPLETED